Martlet Capital

Goals exist to be reached. Again and again. We invest in Deep Tech and Life Science companies that raise the bar. MIG Capital is one of the leading German early-stage VC investors. We turn vision into value by providing financing to young innovative companies in Life Science and Deep Tech across Europe. Since our beginnings in 2004, we have invested more than €650 million in ~50 companies. Today, our portfolio consists of 30 groundbreaking companies.

We bring capital, deep domain expertise, operating experience with high-growth companies, and a far-reaching network to support our entrepreneur partners. Vanedge Capital is an early-stage venture capital fund based in Vancouver and Silicon Valley. As operators, we’ve built and led world-class companies. As investors, we apply our experience and our network to help exceptional entrepreneurs scale their businesses and attract follow-on capital from large institutional investors. We have developed a repeatable investment process that has been refined over more than a decade to create superior returns for our investors. Our investment strategy:Focus on technology themes - Our team’s deep technology background allows us to identify technology trends early, find diamonds in the rough, and attract the best founders as our partners. Mitigate execution risk - Our team’s operating experience and success with rapidly growing, deep technology companies makes us the respected board members that CEOs and other investors seek to help them create momentum, grow fast, and dominate new markets. Attract follow-on capital - Our portfolio companies benefit from a network of top-tier co-investors that we have built over 20 years. Our experience is that institutional capital worldwide is attracted to our de-risked, high-growth investment opportunities in foundational technology companies. Vanedge has $390 million under management.

We invest in opportunities backed by deep science. Xora is an early-stage investment platform of Temasek. We typically invest as a lead or co-lead investor in the Seed and Series A rounds, and later rounds (via our parent company). While we are not limited by geography, we prioritize opportunities that possess a strong linkage with the Singapore science & technology ecosystem. Leveraging the Temasek global network of investors and operating companies, we are active partners to ambitious founders building the next generation of impactful, world-changing companies. Our Team Our team possesses strong technical domain expertise in both physical and life sciences, and the intersection thereof, and are steeped in the nuances of early-stage deep science investing and venture building. We are global citizens with business experience in major markets. Our principles guide our engagement process and our investment decisions.We start with the people on the journey and a shared vision of the future. ​ We look for dogged persistence, unbounded creativity, acute self-awareness, a sense of urgency, and a passion for impact. We embrace both the technical and people complexity of science-based opportunities. ​ We welcome early and frequent contact and appreciate the opportunity to inform an emerging narrative. ​ We prefer brainstorming to pitches, and relationships to transactions. ​ We commit more than capital; we pledge our mindshare and our network.

We support start-ups with investments between $10M and $20M in Europe, Israel and opportunistically on the East coast of the US. Forestay is more than just a VC fund, it’s a family. Forestay was founded as the digital tech arm of a family-oriented investment group that traces its successes in business and its enduring values back across generations. The Bertarelli family founded B-FLEXION (formerly Waypoint Capital), of which Forestay is a part, in 2012 to evolve the management of the capital realised by the sale of Serono, the global leader in biotech and healthcare that they had grown over three generations of leadership. In the decade since, B-FLEXION and its businesses have generated exceptional and lasting value. B-FLEXION is an entrepreneurial private investment firm that partners with sophisticated capital to deliver exceptional value over the generations. As well as its investment funds seeding and building businesses in technology, private equity, real estate and hedge funds, B-FLEXION also focuses on growing operating businesses in transformative industries. Building on its heritage and of that of its founder and Chairman, these have been principally in life sciences, healthcare and digital health.

Our mission is to establish a partnership with companies worldwide and boost Taiwan’s economic growth. Taiwania Capital is a venture capital that focuses on investing in technologies and biotech areas start-ups that are Taiwan or US-based with disruptive and advanced technology. Taiwania Capital is named after Taiwania cryptomerioides, a unique tree species that took its name from Taiwan in 1906. With heights reaching up to 90 meters, the Taiwania tree is one of the tallest tree species in Asia, and surrounding it is a diverse and vibrant ecosystem. By linking technology and capital, Taiwania Capital aspires to also create a robust ecosystem in Taiwan that is rooted in entrepreneurial innovation.

Natural inclination towards Deeptech, Health and Behaviour Changes in Consumers' habits. We offer our investments direct and rapid access to decision-makers in the sectors they aim at transforming. Try us, also happy to coinvest.